Vericel Corp
VCEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000887359
In the last 90 days, Vericel Corp insiders filed 0 open-market purchases and 7 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $2.47B in total; no superinvestor holds it.
Holders of 5% or more of VCEL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vericel Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.10%7.57M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
| State Street Corp | 13G | 5.60%2.81M shares | New | Nov 10, 20251 filing | Nov 10, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Vericel Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 20254:43 PM ET | Brown Capital Management LLC | 13G/A | 3.87%1.95M shares | −2.69 ppfrom 6.56%Below 5% | Sep 30, 2025 | SEC |
| Nov 10, 20259:05 AM ET | State Street Corp | 13G | 5.60%2.81M shares | New | Sep 30, 2025 | SEC |
| May 15, 202512:58 PM ET | Brown Capital Management LLC | 13G/A | 6.56%3.24M shares | 0.00 ppfrom 6.56% | Dec 31, 2024 | SEC |
| Apr 30, 20259:57 AM ET | BlackRock, Inc. | 13G/A | 15.10%7.57M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20254:24 PM ET | Brown Capital Management LLC | 13G/A | 6.56%3.24M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vericel Corp shares.
No Form 144 notices for Vericel Corp are on file.